Research Article - Current Trends in Cardiology (2021) Volume 5, Issue 1
Administration of adenosine during primary PCI for ST- elevation myocardial infarction: Which one offers better clinical outcomes in terms of microvascular obstruction intravenous versus intracoronary?
Aims. Intracoronary administration of adenosine has shown conflicting results. Methods. In this retrospective, singlecentre, blinded clinical study, we assessed whether selective intracoronary administration of adenosine distal to the occlusion site immediately before initial balloon inflation reduces microvascular obstruction (MVO) as assessed with cardiac magnetic resonance imaging (MRI). Using contrast-enhanced sequences, microvascular obstruction (MVO) was calculated. We found 81 patients presenting with STEMI within 12 h from symptom onset who were eligible for the study. In 80/81 (100%) patients receiving the study drug, MRI was performed on Day 1 after primary angioplasty. Results. The prevalence of MVO was reduced in the patients treated with intracoronary adenosine, (45%) compared to 85% of patients who were administered intravenous adenosine ( = 0.0043). We found that the size of MVO in patients receiving intracoronary adenosine was significantly reduced compared to 0.91 g in the intravenous-treated group ( =0.027). There was no statistically significant difference in TIMI flow and clinical outcomes after primary PCI. Conclusion. We found significant evidence that selective high-dose intracoronary administration of adenosine distal to the occlusion site of the culprit lesion in STEMI patients results in a decrease in microvascular obstruction. Author(s): Abdulaziz Aboshahba, Raphael Solomon, Ahmed H Dawood, Gamal Abdelhady, Mohamed Elbordy, Hany Khalaf, Aida Refaat Elrefay
Abstract Full Text PDF